Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH

about

Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH

Item

http://www.wikidata.org/entity/Q57210121

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Immunotherapy with oral admini ...... py for metaflammation and NASH

@en

Immunotherapy with oral admini ...... py for metaflammation and NASH

@nl

type

Item

label

Immunotherapy with oral admini ...... py for metaflammation and NASH

@en

Immunotherapy with oral admini ...... py for metaflammation and NASH

@nl

prefLabel

Immunotherapy with oral admini ...... py for metaflammation and NASH

@en

Immunotherapy with oral admini ...... py for metaflammation and NASH

@nl

P1476

Immunotherapy with oral admini ...... py for metaflammation and NASH

@en

P2093

A Sanyal

http://www.w3.org/2001/XMLSchema#string

K Shailubhai

http://www.w3.org/2001/XMLSchema#string

P2860

Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis

Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease

Decoding cell death signals in liver inflammation

Induction of immunological tolerance by oral anti-CD3

Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells

Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets

Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.

The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice.

Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice

P304

275-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEI.13159

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

193

http://www.w3.org/2001/XMLSchema#string

P50

Yaron Ilan

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29920654

http://www.w3.org/2001/XMLSchema#string

P921

immunology

immunotherapy

P932

6150260

http://www.w3.org/2001/XMLSchema#string